New technology platforms in the development of vaccines for the future
- PMID: 12477412
- DOI: 10.1016/s0264-410x(02)00513-3
New technology platforms in the development of vaccines for the future
Abstract
The desire for improved quality of life in both industrialised and under-developed nations has led to the quest for greater understanding and subsequent prevention and treatment of diseases. Here we discuss some of the latest of modern medicine's approaches to vaccination and disease treatment. Our main subject of discussion being the novel antigen delivery systems termed immunopotentiating reconstituted influenza virosomes (IRIVs) and their use as vaccines. Particular attention is paid to the currently licensed Epaxal and Inflexal V, good examples of the improvements being made in vaccinology. Alternative uses of virosomes such as peptide delivery, cytosolic drug delivery and gene delivery are also considered, highlighting the flexibility of the IRIV formulation and method of action. The paper concludes with consideration of alternative novel approaches to vaccinology including bacterial carriers for DNA vaccines, recombinant MV vaccines and polysaccharide-protein conjugates.
Similar articles
-
Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.Vaccine. 2003 Jan 30;21(7-8):611-5. doi: 10.1016/s0264-410x(02)00567-4. Vaccine. 2003. PMID: 12531327 Review.
-
Inflexal V a trivalent virosome subunit influenza vaccine: production.Vaccine. 2002 Dec 20;20 Suppl 5:B17-23. doi: 10.1016/s0264-410x(02)00512-1. Vaccine. 2002. PMID: 12477413
-
Perspectives: towards a peptide-based vaccine against hepatitis C virus.Mol Immunol. 2001 Dec;38(6):475-84. doi: 10.1016/s0161-5890(01)00083-9. Mol Immunol. 2001. PMID: 11741697
-
Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).Dev Biol (Basel). 2000;103:189-97. Dev Biol (Basel). 2000. PMID: 11214236 Review.
-
Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.Dev Biol Stand. 1998;92:219-23. Dev Biol Stand. 1998. PMID: 9554278
Cited by
-
Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes.Pharmaceutics. 2022 Jun 30;14(7):1385. doi: 10.3390/pharmaceutics14071385. Pharmaceutics. 2022. PMID: 35890282 Free PMC article.
-
Nano toolbox in immune modulation and nanovaccines.Trends Biotechnol. 2022 Oct;40(10):1195-1212. doi: 10.1016/j.tibtech.2022.03.011. Epub 2022 Apr 19. Trends Biotechnol. 2022. PMID: 35450779 Free PMC article. Review.
-
Current Prospects in Peptide-Based Subunit Nanovaccines.Methods Mol Biol. 2022;2412:309-338. doi: 10.1007/978-1-0716-1892-9_16. Methods Mol Biol. 2022. PMID: 34918253
-
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.Methods Mol Biol. 2022;2412:179-231. doi: 10.1007/978-1-0716-1892-9_9. Methods Mol Biol. 2022. PMID: 34918246 Review.
-
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.Pharmaceutics. 2019 Oct 14;11(10):534. doi: 10.3390/pharmaceutics11100534. Pharmaceutics. 2019. PMID: 31615112 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
